{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:36:38Z","timestamp":1783161398761,"version":"3.54.6"},"reference-count":185,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Reversible phosphorylation of proteins on tyrosine residues is an essential signaling mechanism by which diverse cellular processes are closely regulated. The tight temporal and spatial control of the tyrosine phosphorylation status of proteins by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) is critical to cellular homeostasis as well as to adaptations to the external environment. Via regulation of cellular signaling cascades involving other protein kinases and phosphatases, receptors, adaptor proteins, and transcription factors, PTKs and PTPs closely control diverse cellular processes such as proliferation, differentiation, migration, inflammation, and maintenance of cellular barrier function. Given these key regulatory roles, it is not surprising that dysfunction of PTKs and PTPs is important in the pathogenesis of human disease, including many pulmonary diseases. The roles of various PTKs and PTPs in acute lung injury and repair, pulmonary fibrosis, pulmonary vascular disease, and inflammatory airway disease are discussed in this review. It is important to note that although there is overlap among many of these proteins in various disease states, the mechanisms by which they influence the pathogenesis of these conditions differ, suggesting wide-ranging roles for these enzymes and their potential as therapeutic targets.<\/jats:p>","DOI":"10.1165\/rcmb.2018-0049tr","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T15:11:30Z","timestamp":1527606690000},"page":"535-547","source":"Crossref","is-referenced-by-count":21,"title":["The Importance of Tyrosine Phosphorylation Control of Cellular Signaling Pathways in Respiratory Disease: pY and pY Not"],"prefix":"10.1093","volume":"59","author":[{"given":"Yael","family":"Aschner","sequence":"first","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Downey","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, and"},{"name":"Department of Immunology and Microbiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado; and"},{"name":"Department of Medicine"},{"name":"Department of Pediatrics, and"},{"name":"Department of Biomedical Research, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"2026012222050505600_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm2203","article-title":"Mechanisms of specificity in protein phosphorylation","volume":"8","author":"Ubersax","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026012222050505600_bib2","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.febslet.2012.05.008","article-title":"The human phosphatase interactome: an intricate family portrait","volume":"586","author":"Sacco","year":"2012","journal-title":"FEBS Lett"},{"key":"2026012222050505600_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1183\/09031936.00149614","article-title":"The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"45","author":"Grimminger","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.onc.1202251","article-title":"Signaling by dual specificity kinases","volume":"17","author":"Dhanasekaran","year":"1998","journal-title":"Oncogene"},{"key":"2026012222050505600_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20082234","article-title":"Dual-specificity phosphatases: critical regulators with diverse cellular targets","volume":"418","author":"Patterson","year":"2009","journal-title":"Biochem J"},{"key":"2026012222050505600_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cr.7290055","article-title":"The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions","volume":"10","author":"Qu","year":"2000","journal-title":"Cell Res"},{"key":"2026012222050505600_bib7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.onc.1210255","article-title":"Oncogenic re-wiring of cellular signaling pathways","volume":"26","author":"Pawson","year":"2007","journal-title":"Oncogene"},{"key":"2026012222050505600_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"2026012222050505600_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"2026012222050505600_bib10","doi-asserted-by":"crossref","first-page":"00138","DOI":"10.1183\/23120541.00138-2016","article-title":"The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases","volume":"4","author":"Bian","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026012222050505600_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2012.10.103","article-title":"DDR2 plays a role in fibroblast migration independent of adhesion ligand and collagen activated DDR2 tyrosine kinase","volume":"429","author":"Herrera-Herrera","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2026012222050505600_bib12","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/mt.2016.109","article-title":"Targeting of discoidin domain receptor 2 (DDR2) prevents myofibroblast activation and neovessel formation during pulmonary fibrosis","volume":"24","author":"Zhao","year":"2016","journal-title":"Mol Ther"},{"key":"2026012222050505600_bib13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.celrep.2013.04.019","article-title":"Essential regulation of lung surfactant homeostasis by the orphan G protein-coupled receptor GPR116","volume":"3","author":"Yang","year":"2013","journal-title":"Cell Rep"},{"key":"2026012222050505600_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-3-642-41199-1_20","article-title":"GPCRs and arrestins in airways: implications for asthma","volume":"219","author":"Penn","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"2026012222050505600_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/aps.2011.200","article-title":"Role of G protein-coupled receptors in inflammation","volume":"33","author":"Sun","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"2026012222050505600_bib16","doi-asserted-by":"crossref","first-page":"19700","DOI":"10.3390\/ijms151119700","article-title":"Cell-surface receptors transactivation mediated by G protein-coupled receptors","volume":"15","author":"Cattaneo","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2026012222050505600_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/ar020116v","article-title":"Determinants of substrate recognition in nonreceptor tyrosine kinases","volume":"36","author":"Miller","year":"2003","journal-title":"Acc Chem Res"},{"key":"2026012222050505600_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.freeradbiomed.2014.03.005","article-title":"Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of Toll-like receptor 4 signaling","volume":"71","author":"Karki","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"2026012222050505600_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative sstress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"2026012222050505600_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1165\/rcmb.2014-0021TR","article-title":"The crossroads of iron with hypoxia and cellular metabolism: implications in the pathobiology of pulmonary hypertension","volume":"51","author":"Robinson","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0968-0004(03)00174-9","article-title":"Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction","volume":"28","author":"Chiarugi","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"2026012222050505600_bib22","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/febs.12224","article-title":"Redox regulation of protein kinases","volume":"280","author":"Corcoran","year":"2013","journal-title":"FEBS J"},{"key":"2026012222050505600_bib23","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1111\/febs.12898","article-title":"Reactivation of oxidized PTP1B and PTEN by thioredoxin 1","volume":"281","author":"Schwertassek","year":"2014","journal-title":"FEBS J"},{"key":"2026012222050505600_bib24","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.4049\/jimmunol.158.11.5409","article-title":"Inhibition of CD45 during neutrophil activation","volume":"158","author":"Fialkow","year":"1997","journal-title":"J Immunol"},{"key":"2026012222050505600_bib25","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1073\/pnas.0709451105","article-title":"Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling","volume":"105","author":"Juarez","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222050505600_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2007.03.021","article-title":"Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2","volume":"43","author":"Weibrecht","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"2026012222050505600_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.redox.2015.12.002","article-title":"Redox-dependent regulation of epidermal growth factor receptor signaling","volume":"8","author":"Heppner","year":"2016","journal-title":"Redox Biol"},{"key":"2026012222050505600_bib28","doi-asserted-by":"crossref","first-page":"2005.0010","DOI":"10.1038\/msb4100014","article-title":"A comprehensive pathway map of epidermal growth factor receptor signaling","volume":"1","author":"Oda","year":"2005","journal-title":"Mol Syst Biol"},{"key":"2026012222050505600_bib29","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2026012222050505600_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell Biol"},{"key":"2026012222050505600_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15216540210811","article-title":"Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor","volume":"53","author":"Tiganis","year":"2002","journal-title":"IUBMB Life"},{"key":"2026012222050505600_bib32","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026012222050505600_bib33","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"2026012222050505600_bib34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/rccm.201110-1842ED","article-title":"Idiopathic pulmonary fibrosis: increased survival with \u201cgastroesophageal reflux therapy\u201d: fact or fallacy?","volume":"184","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30007-9","article-title":"Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?","volume":"6","author":"Wolters","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026012222050505600_bib37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"2026012222050505600_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1165\/rcmb.2015-0391TR","article-title":"Transforming growth factor-\u03b2: master regulator of the respiratory system in health and disease","volume":"54","author":"Aschner","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-\u03b2 on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"2026012222050505600_bib41","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","article-title":"Src phosphorylates Tyr284 in TGF-\u03b2 type II receptor and regulates TGF-\u03b2 stimulation of p38 MAPK during breast cancer cell proliferation and invasion","volume":"67","author":"Galliher","year":"2007","journal-title":"Cancer Res"},{"key":"2026012222050505600_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08977199009043908","article-title":"Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF \u03b2 receptor subtype and decreases the growth inhibitory response to TGF-\u03b21","volume":"3","author":"Fafeur","year":"1990","journal-title":"Growth Factors"},{"key":"2026012222050505600_bib43","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.celrep.2012.10.021","article-title":"FGF regulates TGF-\u03b2 signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep"},{"key":"2026012222050505600_bib44","doi-asserted-by":"crossref","first-page":"33407","DOI":"10.1038\/srep33407","article-title":"Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF\u03b2)-dependent smooth muscle cell phenotype modulation","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"2026012222050505600_bib45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbadis.2012.06.008","article-title":"Tyrosine kinase signaling in fibrotic disorders: translation of basic research to human disease","volume":"1832","author":"Beyer","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2026012222050505600_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI114808","article-title":"Platelet-derived growth factor in idiopathic pulmonary fibrosis","volume":"86","author":"Antoniades","year":"1990","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib47","first-page":"539","article-title":"Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo","volume":"149","author":"Yi","year":"1996","journal-title":"Am J Pathol"},{"key":"2026012222050505600_bib48","first-page":"L72","article-title":"Induction of PDGF receptor-\u03b1 in rat myofibroblasts during pulmonary fibrogenesis in vivo","volume":"274","author":"Bonner","year":"1998","journal-title":"Am J Physiol"},{"key":"2026012222050505600_bib49","first-page":"L311","article-title":"Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level","volume":"276","author":"Gurujeyalakshmi","year":"1999","journal-title":"Am J Physiol"},{"key":"2026012222050505600_bib50","doi-asserted-by":"crossref","first-page":"L182","DOI":"10.1152\/ajplung.00083.2003","article-title":"Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis","volume":"286","author":"Zhuo","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-9440(10)65115-2","article-title":"Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats","volume":"155","author":"Rice","year":"1999","journal-title":"Am J Pathol"},{"key":"2026012222050505600_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1164\/rccm.200811-1794OC","article-title":"Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"180","author":"Gupte","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib53","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.86.3.802","article-title":"Purification and characterization of a newly identified growth factor specific for epithelial cells","volume":"86","author":"Rubin","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222050505600_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir Res"},{"key":"2026012222050505600_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/jir.2011.0079","article-title":"The fibroblast growth factor pathway and its role in the pathogenesis of lung disease","volume":"32","author":"Dosanjh","year":"2012","journal-title":"J Interferon Cytokine Res"},{"key":"2026012222050505600_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1248\/bpb.35.731","article-title":"Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"35","author":"Yu","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"2026012222050505600_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00408-004-2534-z","article-title":"Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts","volume":"183","author":"Hetzel","year":"2005","journal-title":"Lung"},{"key":"2026012222050505600_bib58","first-page":"2037","article-title":"Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders","volume":"149","author":"Inoue","year":"1996","journal-title":"Am J Pathol"},{"key":"2026012222050505600_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2012-0100TR","article-title":"Human epidermal growth factor receptor signaling in acute lung injury","volume":"47","author":"Finigan","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1183\/09031936.00146413","article-title":"Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities","volume":"44","author":"Vallath","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib61","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1165\/ajrcmb.11.5.7524566","article-title":"Expression of transforming growth factor-\u03b1 and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats","volume":"11","author":"Madtes","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib62","first-page":"57","article-title":"Overexpression of transforming growth factor-\u03b1 and epidermal growth factor-receptor in idiopathic pulmonary fibrosis","volume":"16","author":"Baughman","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012222050505600_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/japplphysiol.01360.2004","article-title":"Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice","volume":"99","author":"Nethery","year":"2005","journal-title":"J Appl Physiol (1985)"},{"key":"2026012222050505600_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/jpet.114.216044","article-title":"Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis","volume":"351","author":"Hu","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"2026012222050505600_bib65","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-\u03b2 and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib66","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1096\/fj.11-200139","article-title":"Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis","volume":"26","author":"Zhang","year":"2012","journal-title":"FASEB J"},{"key":"2026012222050505600_bib67","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.4049\/jimmunol.1303463","article-title":"Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis","volume":"193","author":"Tao","year":"2014","journal-title":"J Immunol"},{"key":"2026012222050505600_bib68","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.201602-0329OC","article-title":"SH2 domain-containing phosphatase-2 is a novel antifibrotic regulator in pulmonary fibrosis","volume":"195","author":"Tzouvelekis","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib69","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1073\/pnas.87.16.6112","article-title":"Cloning and expression of a widely expressed receptor tyrosine phosphatase","volume":"87","author":"Sap","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222050505600_bib70","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ajpath.2014.01.016","article-title":"Protein tyrosine phosphatase \u03b1 mediates profibrotic signaling in lung fibroblasts through TGF-\u03b2 responsiveness","volume":"184","author":"Aschner","year":"2014","journal-title":"Am J Pathol"},{"key":"2026012222050505600_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.39442","article-title":"Receptor protein tyrosine phosphatase \u03b1-mediated enhancement of rheumatoid synovial fibroblast signaling and promotion of arthritis in mice","volume":"68","author":"Stanford","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026012222050505600_bib72","doi-asserted-by":"crossref","first-page":"e70659","DOI":"10.1371\/journal.pone.0070659","article-title":"Role of PTP\u03b1 in the destruction of periodontal connective tissues","volume":"8","author":"Rajshankar","year":"2013","journal-title":"PLoS One"},{"key":"2026012222050505600_bib73","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"2026012222050505600_bib74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2026012222050505600_bib75","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib76","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"2026012222050505600_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1183\/09031936.00196412","article-title":"The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance","volume":"43","author":"Burnham","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1165\/rcmb.2008-0348TR","article-title":"Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury","volume":"40","author":"Zemans","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib79","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1165\/rcmb.2011-0271OC","article-title":"Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation","volume":"46","author":"Grinnell","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib80","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1165\/rcmb.2013-0489OC","article-title":"SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function","volume":"52","author":"Chichger","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib81","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1378\/chest.14-0397","article-title":"Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS","volume":"146","author":"Aschner","year":"2014","journal-title":"Chest"},{"key":"2026012222050505600_bib82","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0968-0004(03)00193-2","article-title":"VEGF-receptor signal transduction","volume":"28","author":"Cross","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"2026012222050505600_bib83","first-page":"765","article-title":"Neovasculature induced by vascular endothelial growth factor is fenestrated","volume":"57","author":"Roberts","year":"1997","journal-title":"Cancer Res"},{"key":"2026012222050505600_bib84","doi-asserted-by":"crossref","first-page":"L209","DOI":"10.1152\/ajplung.00185.2005","article-title":"Vascular endothelial growth factor in the lung","volume":"290","author":"Voelkel","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1097-2765(00)80221-X","article-title":"Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability","volume":"4","author":"Eliceiri","year":"1999","journal-title":"Mol Cell"},{"key":"2026012222050505600_bib86","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1164\/rccm.2105057","article-title":"A role for vascular endothelial growth factor in acute and resolving lung injury","volume":"166","author":"Thickett","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib87","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/thx.2005.040204","article-title":"Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?","volume":"61","author":"Medford","year":"2006","journal-title":"Thorax"},{"key":"2026012222050505600_bib88","doi-asserted-by":"crossref","first-page":"L585","DOI":"10.1152\/ajplung.00048.2002","article-title":"Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury","volume":"283","author":"Karmpaliotis","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib89","doi-asserted-by":"crossref","first-page":"L710","DOI":"10.1152\/ajplung.00044.2003","article-title":"Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice","volume":"285","author":"Gurkan","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib90","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1096\/fasebj.14.10.1362","article-title":"Involvement of the epidermal growth factor receptor in epithelial repair in asthma","volume":"14","author":"Puddicombe","year":"2000","journal-title":"FASEB J"},{"key":"2026012222050505600_bib91","first-page":"L883","article-title":"Mechanical strain inhibits repair of airway epithelium in vitro","volume":"274","author":"Savla","year":"1998","journal-title":"Am J Physiol"},{"key":"2026012222050505600_bib92","first-page":"L17","article-title":"Growth factors alter neonatal type II alveolar epithelial cell proliferation","volume":"266","author":"Ryan","year":"1994","journal-title":"Am J Physiol"},{"key":"2026012222050505600_bib93","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1165\/ajrcmb.16.4.9115748","article-title":"Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells","volume":"16","author":"Leslie","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib94","doi-asserted-by":"crossref","first-page":"L1184","DOI":"10.1152\/ajplung.2000.279.6.L1184","article-title":"Interleukin-1\u03b2 augments in vitro alveolar epithelial repair","volume":"279","author":"Geiser","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.trsl.2008.10.004","article-title":"Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice","volume":"152","author":"Bierman","year":"2008","journal-title":"Transl Res"},{"key":"2026012222050505600_bib96","doi-asserted-by":"crossref","first-page":"L883","DOI":"10.1152\/ajplung.00203.2001","article-title":"Cyclic stretch activates ERK1\/2 via G proteins and EGFR in alveolar epithelial cells","volume":"282","author":"Correa-Meyer","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib97","doi-asserted-by":"crossref","first-page":"L56","DOI":"10.1152\/ajplung.00159.2010","article-title":"The Rac1\/JNK pathway is critical for EGFR-dependent barrier formation in human airway epithelial cells","volume":"300","author":"Terakado","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib98","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1152\/japplphysiol.00681.2004","article-title":"Effects of transdifferentiation and EGF on claudin isoform expression in alveolar epithelial cells","volume":"98","author":"Chen","year":"2005","journal-title":"J Appl Physiol (1985)"},{"key":"2026012222050505600_bib99","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1152\/japplphysiol.00239.2007","article-title":"Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2","volume":"103","author":"Faress","year":"2007","journal-title":"J Appl Physiol (1985)"},{"key":"2026012222050505600_bib100","doi-asserted-by":"crossref","first-page":"L129","DOI":"10.1152\/ajplung.00261.2005","article-title":"Src protein tyrosine kinase family and acute inflammatory responses","volume":"291","author":"Okutani","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.surg.2004.05.029","article-title":"The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo","volume":"136","author":"Khadaroo","year":"2004","journal-title":"Surgery"},{"key":"2026012222050505600_bib102","doi-asserted-by":"crossref","first-page":"L1282","DOI":"10.1152\/ajplung.00349.2003","article-title":"Activation of the STAT pathway in acute lung injury","volume":"286","author":"Severgnini","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib103","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/jbc.271.2.695","article-title":"Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation","volume":"271","author":"Hanke","year":"1996","journal-title":"J Biol Chem"},{"key":"2026012222050505600_bib104","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.200407-981OC","article-title":"Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury","volume":"171","author":"Severgnini","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib105","doi-asserted-by":"crossref","first-page":"23464","DOI":"10.1074\/jbc.271.38.23464","article-title":"Regulation of Src family tyrosine kinase activities in adherent human neutrophils: evidence that reactive oxygen intermediates produced by adherent neutrophils increase the activity of the p58c-fgr and p53\/56lyn tyrosine kinases","volume":"271","author":"Yan","year":"1996","journal-title":"J Biol Chem"},{"key":"2026012222050505600_bib106","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.4049\/jimmunol.164.8.4321","article-title":"Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases","volume":"164","author":"M\u00f3csai","year":"2000","journal-title":"J Immunol"},{"key":"2026012222050505600_bib107","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1091\/mbc.e12-01-0038","article-title":"The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of \u03b2-catenin phosphorylation","volume":"23","author":"Timmerman","year":"2012","journal-title":"Mol Biol Cell"},{"key":"2026012222050505600_bib108","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1083\/jcb.143.2.523","article-title":"The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage","volume":"143","author":"Balsamo","year":"1998","journal-title":"J Cell Biol"},{"key":"2026012222050505600_bib109","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20131190","article-title":"Evidence of a common mechanism of disassembly of adherens junctions through G\u03b113 targeting of VE-cadherin","volume":"211","author":"Gong","year":"2014","journal-title":"J Exp Med"},{"key":"2026012222050505600_bib110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI77701","article-title":"HIF2\u03b1 signaling inhibits adherens junctional disruption in acute lung injury","volume":"125","author":"Gong","year":"2015","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib111","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.1038\/sj.onc.1210566","article-title":"HIF-2\u03b1 specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites","volume":"26","author":"Le Bras","year":"2007","journal-title":"Oncogene"},{"key":"2026012222050505600_bib112","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.CIR.0000156326.48823.55","article-title":"Pathogenesis of pulmonary arterial hypertension: the need for multiple hits","volume":"111","author":"Yuan","year":"2005","journal-title":"Circulation"},{"key":"2026012222050505600_bib113","doi-asserted-by":"crossref","first-page":"32023","DOI":"10.1016\/S0021-9258(18)31591-6","article-title":"Platelet-derived growth factor receptor signals","volume":"269","author":"Claesson-Welsh","year":"1994","journal-title":"J Biol Chem"},{"key":"2026012222050505600_bib114","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0033-1356494","article-title":"Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?","volume":"34","author":"Godinas","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012222050505600_bib115","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.200911-1663OC","article-title":"Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases","volume":"183","author":"ten Freyhaus","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib116","doi-asserted-by":"crossref","first-page":"L1162","DOI":"10.1152\/ajplung.00180.2004","article-title":"A role for platelet-derived growth factor \u03b2-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling","volume":"288","author":"Jankov","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib117","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib118","first-page":"H1948","article-title":"Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension","volume":"275","author":"Partovian","year":"1998","journal-title":"Am J Physiol"},{"key":"2026012222050505600_bib119","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/hc4201.097838","article-title":"Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension","volume":"104","author":"Campbell","year":"2001","journal-title":"Circulation"},{"key":"2026012222050505600_bib120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J"},{"key":"2026012222050505600_bib121","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.953","article-title":"Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis","volume":"195","author":"Tuder","year":"2001","journal-title":"J Pathol"},{"key":"2026012222050505600_bib122","doi-asserted-by":"crossref","first-page":"L668","DOI":"10.1152\/ajplung.00491.2005","article-title":"Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension","volume":"291","author":"Taraseviciene-Stewart","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/rccm.201104-0664ED","article-title":"Emerging role of c-kit+ progenitor cells in pulmonary hypertension","volume":"184","author":"Schwarz","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib124","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201006-0905OC","article-title":"c-kit-Positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension","volume":"184","author":"Montani","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib125","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1183\/09031936.00045710","article-title":"Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension","volume":"37","author":"Gambaryan","year":"2011","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200811-1682OC","article-title":"Role of epidermal growth factor inhibition in experimental pulmonary hypertension","volume":"181","author":"Dahal","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib127","first-page":"S167","article-title":"Airway inflammation in chronic obstructive pulmonary disease","volume":"6","author":"Angelis","year":"2014","journal-title":"J Thorac Dis"},{"key":"2026012222050505600_bib128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fmicb.2013.00263","article-title":"Pathology of asthma","volume":"4","author":"Kudo","year":"2013","journal-title":"Front Microbiol"},{"key":"2026012222050505600_bib129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5455\/msm.2012.24.100-105","article-title":"Asthma and chronic obstructive pulmonary disease (COPD) \u2013 differences and similarities","volume":"24","author":"Cukic","year":"2012","journal-title":"Mater Sociomed"},{"issue":"5","key":"2026012222050505600_bib130","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026012222050505600_bib131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaci.2006.10.025","article-title":"Severe asthma: lessons from the Severe Asthma Research Program","volume":"119","author":"Wenzel","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026012222050505600_bib132","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/pr.116.012518","article-title":"Kinases as novel therapeutic targets in asthma and chronic obstructive pulmonary disease","volume":"68","author":"Barnes","year":"2016","journal-title":"Pharmacol Rev"},{"key":"2026012222050505600_bib133","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1164\/ajrccm.157.6.9609040","article-title":"Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway","volume":"157","author":"Amishima","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib134","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1067\/mai.2002.120274","article-title":"Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects","volume":"109","author":"Polosa","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2026012222050505600_bib135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ACI.0b013e32834ecb4f","article-title":"The potential use of tyrosine kinase inhibitors in severe asthma","volume":"12","author":"Guntur","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2026012222050505600_bib136","doi-asserted-by":"crossref","first-page":"L414","DOI":"10.1152\/ajplung.00346.2010","article-title":"Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma","volume":"300","author":"Le Cras","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib137","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/rcmb.2005-0386OC","article-title":"Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium","volume":"34","author":"Casalino-Matsuda","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib138","doi-asserted-by":"crossref","first-page":"L165","DOI":"10.1152\/ajplung.2001.280.1.L165","article-title":"Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke","volume":"280","author":"Takeyama","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib139","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1309\/W1AXKGT7UA37X257","article-title":"Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease","volume":"125","author":"de Boer","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"2026012222050505600_bib140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2010-0277OC","article-title":"In vivo role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung","volume":"45","author":"Hirota","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000094180","article-title":"Variant in promoter region of platelet-derived growth factor receptor-\u03b1 (PDGFR\u03b1) gene is associated with the severity and allergic status of childhood asthma","volume":"141","author":"Wu","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"2026012222050505600_bib142","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000085106","article-title":"Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children","volume":"137","author":"Leung","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"2026012222050505600_bib143","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/bbrc.2001.5788","article-title":"Syk expression and novel function in a wide variety of tissues","volume":"288","author":"Yanagi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2026012222050505600_bib144","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1189\/jlb.69.2.224","article-title":"Characteristics of the free cytosolic calcium timelag following IgE-mediated stimulation of human basophils: significance for the nonreleasing basophil phenotype","volume":"69","author":"MacGlashan","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2026012222050505600_bib145","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1002\/eji.201141502","article-title":"Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo","volume":"41","author":"Wex","year":"2011","journal-title":"Eur J Immunol"},{"key":"2026012222050505600_bib146","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0003-2697(03)00026-5","article-title":"Development of a high-throughput fluoroimmunoassay for Syk kinase and Syk kinase inhibitors","volume":"315","author":"Yamamoto","year":"2003","journal-title":"Anal Biochem"},{"key":"2026012222050505600_bib147","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1165\/rcmb.2005-0298OC","article-title":"Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation","volume":"34","author":"Matsubara","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib148","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1038\/s41598-017-09349-0","article-title":"Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1\/2, PI3K\u03b4\/Akt and NF\u03baB induction in a murine asthma model","volume":"7","author":"El-Hashim","year":"2017","journal-title":"Sci Rep"},{"key":"2026012222050505600_bib149","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1165\/rcmb.2013-0258OC","article-title":"Cigarette smoke activates the proto-oncogene c-Src to promote airway inflammation and lung tissue destruction","volume":"50","author":"Geraghty","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib150","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI0215786","article-title":"JAK-STAT signaling in asthma","volume":"109","author":"Pernis","year":"2002","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4110\/in.2010.10.1.1","article-title":"Role of IL-23 and Th17 cells in airway inflammation in asthma","volume":"10","author":"Nakajima","year":"2010","journal-title":"Immune Netw"},{"key":"2026012222050505600_bib152","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2007.12.024","article-title":"The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia","volume":"582","author":"Kudlacz","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2026012222050505600_bib153","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI16440","article-title":"Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma","volume":"111","author":"Kwak","year":"2003","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib154","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2567.2009.03139.x","article-title":"The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development","volume":"128","author":"Pouliot","year":"2009","journal-title":"Immunology"},{"key":"2026012222050505600_bib155","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.rmed.2009.06.016","article-title":"PTEN identified as important risk factor of chronic obstructive pulmonary disease","volume":"103","author":"Hosgood","year":"2009","journal-title":"Respir Med"},{"key":"2026012222050505600_bib156","doi-asserted-by":"crossref","first-page":"L230","DOI":"10.1152\/ajplung.00382.2016","article-title":"Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD","volume":"313","author":"Yanagisawa","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222050505600_bib157","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/smim.2000.0223","article-title":"Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling","volume":"12","author":"Zhang","year":"2000","journal-title":"Semin Immunol"},{"key":"2026012222050505600_bib158","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI15719","article-title":"src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation","volume":"111","author":"Kamata","year":"2003","journal-title":"J Clin Invest"},{"key":"2026012222050505600_bib159","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2010.01.102","article-title":"The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stress","volume":"393","author":"Jang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"2026012222050505600_bib160","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4049\/jimmunol.0901972","article-title":"SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung","volume":"184","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"2026012222050505600_bib161","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2008-0225OC","article-title":"A critical role of SHP-1 in regulation of type 2 inflammation in the lung","volume":"40","author":"Oh","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222050505600_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12248","article-title":"Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases","volume":"176","author":"Patterson","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2026012222050505600_bib163","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2012.02.001","article-title":"Tyrosine kinase inhibitors in lung cancer","volume":"26","author":"Thomas","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"2026012222050505600_bib164","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012222050505600_bib165","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012222050505600_bib166","first-page":"101","article-title":"OFEV (nintedanib): first tyrosine kinase inhibitor approved for the treatment of patients with idiopathic pulmonary fibrosis","volume":"8","author":"Fala","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"2026012222050505600_bib167","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-13-1256","article-title":"SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis","volume":"74","author":"Tyryshkin","year":"2014","journal-title":"Cancer Res"},{"key":"2026012222050505600_bib168","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","article-title":"Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice","volume":"171","author":"Aono","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib169","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1164\/rccm.200702-178OC","article-title":"Role of \u03b11-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice","volume":"176","author":"Azuma","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","article-title":"Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results","volume":"181","author":"Daniels","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222050505600_bib171","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/gtc.12022","article-title":"Activity-based kinase profiling of approved tyrosine kinase inhibitors","volume":"18","author":"Kitagawa","year":"2013","journal-title":"Genes Cells"},{"key":"2026012222050505600_bib172","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5306\/wjco.v2.i2.80","article-title":"Tyrosine kinase inhibitors: Multi-targeted or single-targeted?","volume":"2","author":"Broekman","year":"2011","journal-title":"World J Clin Oncol"},{"key":"2026012222050505600_bib173","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.biochem.75.103004.142657","article-title":"Tyrphostins and other tyrosine kinase inhibitors","volume":"75","author":"Levitzki","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"2026012222050505600_bib174","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-pharmtox-011112-140341","article-title":"Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance","volume":"53","author":"Levitzki","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026012222050505600_bib176","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00280-011-1737-2","article-title":"Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight","volume":"68","author":"Min","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026012222050505600_bib177","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40264-016-0450-9","article-title":"Tyrosine kinase inhibitor-induced interstitial lung disease: clinical features, diagnostic challenges, and therapeutic dilemmas","volume":"39","author":"Shah","year":"2016","journal-title":"Drug Saf"},{"key":"2026012222050505600_bib178","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MCP.0000000000000412","article-title":"Pulmonary arterial hypertension induced by tyrosine kinase inhibitors","volume":"23","author":"Weatherald","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"2026012222050505600_bib179","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"2026012222050505600_bib180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09031936.00211811","article-title":"Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries","volume":"41","author":"Nagaraj","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012222050505600_bib181","first-page":"85","article-title":"Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a phase III study","volume":"5","author":"Wang","year":"2013","journal-title":"Clin Pharmacol"},{"key":"2026012222050505600_bib182","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2174\/138161210791209027","article-title":"Targeting protein tyrosine phosphatases for anticancer drug discovery","volume":"16","author":"Scott","year":"2010","journal-title":"Curr Pharm Des"},{"key":"2026012222050505600_bib183","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/mol.108.053140","article-title":"Targeting protein serine\/threonine phosphatases for drug development","volume":"75","author":"McConnell","year":"2009","journal-title":"Mol Pharmacol"},{"key":"2026012222050505600_bib184","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01075941","article-title":"In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus","volume":"153","author":"Goldfine","year":"1995","journal-title":"Mol Cell Biochem"},{"key":"2026012222050505600_bib185","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein tyrosine phosphatases as potential therapeutic targets","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol Sin"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/59\/5\/535\/66466453\/ajrcmb_59_5_535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/59\/5\/535\/66466453\/ajrcmb_59_5_535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:07:54Z","timestamp":1769137674000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/59\/5\/535\/8430525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":185,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2018-0049tr","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,11,1]]}}}